Ajani J - Search Results

1

Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-institutional Analysis.

Allen CJ, Pointer DT Jr, Blumenthaler AN, Mehta RJ, Hoffe SE, Minsky BD, Smith GL, Blum M, Mansfield PF, Ikoma N, Das P, Ajani J, Dineen SP, Fleming JB, Badgwell BD, Pimiento JM. Allen CJ, et al. Among authors: ajani j. Ann Surg. 2021 Oct 1;274(4):544-548. doi: 10.1097/SLA.0000000000005007. Ann Surg. 2021. PMID: 34132693 Free PMC article.

2

Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.

Ajani JA, Ota DM, Jessup JM, Ames FC, McBride C, Boddie A, Levin B, Jackson DE, Roh M, Hohn D. Ajani JA, et al. Cancer. 1991 Oct 1;68(7):1501-6. doi: 10.1002/1097-0142(19911001)68:7<1501::aid-cncr2820680706>3.0.co;2-l. Cancer. 1991. PMID: 1893349

3

Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.

Ajani JA, Roth JA, Ryan B, McMurtrey M, Rich TA, Jackson DE, Abbruzzese JL, Levin B, DeCaro L, Mountain C. Ajani JA, et al. J Clin Oncol. 1990 Jul;8(7):1231-8. doi: 10.1200/JCO.1990.8.7.1231. J Clin Oncol. 1990. PMID: 2358838

4

Multidisciplinary therapy for esophageal cancer.

Roth JA, Ajani JA, Rich TA. Roth JA, et al. Among authors: ajani ja. Adv Surg. 1990;23:239-60. Adv Surg. 1990. PMID: 2403459 Review.

5

Preoperative infusional chemoradiation therapy for stage T3 rectal cancer.

Rich TA, Skibber JM, Ajani JA, Buchholz DJ, Cleary KR, Dubrow RA, Levin B, Lynch PM, Meterissian SH, Roubein LD, et al. Rich TA, et al. Among authors: ajani ja. Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):1025-9. doi: 10.1016/0360-3016(95)00020-y. Int J Radiat Oncol Biol Phys. 1995. PMID: 7607922

6

Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction.

Ajani JA, Roth JA, Putnam JB, Walsh G, Lynch PM, Roubein LD, Ryan MB, Natrajan G, Gould P. Ajani JA, et al. Eur J Cancer. 1995;31A(5):665-70. doi: 10.1016/0959-8049(94)00318-y. Eur J Cancer. 1995. PMID: 7640036

7

Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.

Ajani JA, Mansfield PF, Ota DM. Ajani JA, et al. World J Surg. 1995 Mar-Apr;19(2):216-20. doi: 10.1007/BF00308629. World J Surg. 1995. PMID: 7754626 Review.

8

Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach.

Kim YH, Ajani JA, Ota DM, Lynch P, Roth JA. Kim YH, et al. Among authors: ajani ja. Cancer. 1995 Jan 15;75(2):451-6. doi: 10.1002/1097-0142(19950115)75:2<451::aid-cncr2820750207>3.0.co;2-u. Cancer. 1995. PMID: 7812915

9

Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma.

Meterissian S, Skibber J, Rich T, Roubein L, Ajani J, Cleary K, Ota DM. Meterissian S, et al. Among authors: ajani j. Ann Surg Oncol. 1994 Mar;1(2):111-6. doi: 10.1007/BF02303553. Ann Surg Oncol. 1994. PMID: 7834435

10

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.

Moore DF Jr, Pazdur R, Abbruzzese JL, Ajani JA, Dubovsky DW, Wade JL 3rd, Belt RJ, Mangold C, Bready B, Winn RJ. Moore DF Jr, et al. Among authors: ajani ja. Ann Oncol. 1994 Mar;5(3):286-7. doi: 10.1093/oxfordjournals.annonc.a058810. Ann Oncol. 1994. PMID: 8186177 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

937 results

Search Page

Filters